News

A study suggests young black MSM can experience delays in PrEP initiation if they do not have health insurance, even if expanded access through manufacturer assistance programs is offered.

Elizabeth Hirsch, PharmD, and Delaney Hart, PharmD, discuss their poster at IDWeek 2019.

Millions of women and infants remain vulnerable to influenza and pertussis despite recommendations for vaccinations in pregnancy, according to a CDC report.

Deanna Buehrle, PharmD, discusses her study on bloodstream infections in solid organ transplant recipients.

The study focused on women living with HIV in areas where TB is highly prevalent.

Evaluating the impact of the 2016 FDA boxed warning on fluoroquinolone prescribing rates for uncomplicated urinary tract infections.

Candidemia is the fourth most common health care-associated infection. To improve hospitalized patients’ safety, infectious disease physicians should be consulted.

Here is a look at infectious disease-related US Food and Drug Administration (FDA) news from the week of October 6, 2019.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

Keith S. Kaye, MD, MPH, discusses the current treatment landscape for pneumonia in the ICU setting, and previews the topline results of the phase 3 RESTORE-IMI 2 trial.

Reported hepatitis A vaccinations consistently fell below potentially achievable coverage between 2008 and 2017, highlighting the need for to improve simultaneous administration of childhood vaccines, according to the CDC.

As of October 8, 2019, a total of 21 individuals have been infected with the outbreak strain of Salmonella across 13 states.

An accidental discovery of a thermostable protein leads to the creation of an engineered vaccine that promises to be a boon to developing countries.

Anandi Sheth, MD, MSc, summarizes her presentation on HIV prevention in women and discusses the need for more women in pre-exposure prophylaxis research.

HIV testing rates have improved among men who have sex with men in Africa, but new research indicates the developments are not enough to meet the UNAID’s 90-90-90 targets.

When guidelines are quickly implemented for C diff treatment recommendations, the changes are reflected quickly.

Health officials provide 4 strategies to improve C auris surveillance efforts.

Newborn dried blood spot testing is not sensitive enough to diagnose all cases of congenital cytomegalovirus (cCMV) in infants with sensorineural hearing loss.

Regulations are redundant and lack specific standards for hospital compliance, experts say.

University of Illinois at Chicago investigators compared virologic failure among MSM and transgender women receiving HIV care at a community-based model with those receiving care at a hospital-based model.

In the absence of interpretive criteria, Fosfomycin has been used to treat Psuedomonas aeruginosa infections, but new research suggests that this option should be evaluated further.

The Closing Plenary of IDWeek 2019 discussed the challenges of vaccination and the optimism that we may be on the path to eradicating some global infectious diseases.

Millennials are a major population affected by the opioid crisis, which has now translated to an increase in hepatitis C virus infections among the generation.

Long-term care facilities participating in a statewide initiative in Nebraska saw improvements in antimicrobial stewardship, including drops in antibiotic starts and C diff infections.

The announcement came just 1 day after health officials in New York State declared the end of the Rockland County measles outbreak.

In the first study of its kind, investigators found ceftolozane/tazobactam is more effective than the most common therapy for multidrug-resistant P aeruginosa.

For individuals living with HIV, switching suppressive HIV regimens may be considered for a variety of reasons including treatment simplification, improved safety and tolerability, drug-drug interactions, or cost.

ART-related medication errors can occur and lead to suboptimal therapy and in some cases treatment resistance.